How Virtua Health vets, trains, and re-engineers its imaging technology to safely anonymize data for clinical trial research.
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Waiver Of Consent vs Waiver Of Written Consent
Learn the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials, and the importance of informed consent, particularly in the context of virtual trials.
-
How Do Site Payments Impact Clinical Trial Sustainability?
Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,
-
The Case For Cognitive Assessments In Phase 1 Clinical Trials
Regulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.
-
Enhancing The Accessibility And Affordability Of Healthcare
The March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.
-
Keep Up With These 5 Patient Engagement And Recruitment Trends
From decentralized trials to real world data, take a look at top trends, their impact on patient enrollment and more, as well as ways to stay ahead of the curve.
-
Driving Enrollment Predictability In Clinical Trial Timelines
Missed enrollment targets cost millions—TA Scan’s benchmarking and simulation tools empower sponsors to forecast with confidence, optimize site strategy, and keep budgets on track.
-
Navigating The eCOA Vendor Landscape In 2025
This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
Fighting COVID-19 Like A Pro
Explore how the use of electronic Clinical Outcomes Assessments (eCOAs) can be rapidly implemented to capture patient reported outcomes (PROs).
-
How Cara Therapeutics Increased Compliance And Reduced Study Team Burden
Delve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
- AI Governance Is Becoming A Competitive Edge In Trials
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
RECENT NEWSLETTERS
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations